Impact BioMedical Inc.
IBO | AMEX
$4.10
+$0.30 (+7.89%)
Nov 2, 2026, 10:31 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 11.36M | -2.3M | -1.29M | -56.09M | -48.88M | -35.41M | -35.1M | 2.65M | -4.25M | -4.46M | -4.16M | -6.45M | -7.46M | -7.09M | -7.1M | -3.25M | -1.89M | -1.16M | -487.42K | -1.03M |
Depreciation & Amortization | 1.43M | 1.43M | 1.43M | 1.26M | 1.35M | 1.34M | 1.34M | 1.22M | 1.12M | 1.12M | 1.12M | 1.12M | 1.12M | 1.12M | 1.11M | 1.11M | 1.11M | 834.53K | 556.53K | 278.53K |
Stock-Based Compensation | 13K | -14K | 17K | 5K | 4K | 31K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | 809K | 85K | 131K | 487.55K | 72.6K | -20.4K | -314.4K | -399.95K | 32K | 50K | 143K | -40K | -21K | -90K | -3K | -12K | -1.73K | 75.27K | 80.27K | 80.54K |
Other Non-Cash Items | -12.2M | 1.1M | -68.06K | 51.51M | 43.32M | 29.93M | 29.86M | -7.49M | 160K | 135K | -251K | 4.04M | 3.88M | 3.83M | 3.95M | -582K | -521.96K | -454.96K | -377.96K | -212.93K |
Deferred Income Tax | -2.58M | -2.58M | -2.58M | 47.46K | 47.46K | 47.46K | 47.46K | n/a | n/a | n/a | n/a | -1.88M | -621K | -621K | -621K | 91K | -1.17M | -1.17M | -1.17M | -82.1K |
Change in Working Capital | 1.47M | 684K | 600K | -533.49K | -763.27K | -832.27K | -837.27K | 303.23K | 717K | 887K | 436K | 392K | 171K | 41K | 421K | -39K | 105.21K | 128.21K | 193.21K | 126.08K |
Operating Cash Flow | -508K | -1.67M | -1.89M | -3.8M | -4.92M | -4.89M | -4.69M | -3.32M | -2.25M | -2.32M | -2.85M | -2.78M | -2.91M | -2.72M | -2.24M | -2.67M | -2.36M | -1.82M | -1.28M | -919.89K |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1K | -13K | -18K | -294K | -293K | -281K | -276K | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -53K | -65K | -84K | -1.09M | -1.04M | -1.03M | -1.64M |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 3K | 1K | 3K | 2K | 2.35K | 3.35K | 2.35K | 3.35K | 2K | 2K | 3K | 3K | 2K | 86K | -8K | -934K | -2.31M | -2.4M | -2.3M | -1.38M |
Investing Cash Flow | 3K | 1K | 3K | 2K | 2.35K | 3.35K | 2.35K | 3.35K | 1K | -11K | -15K | -291K | -291K | -248K | -349K | -1.02M | -3.41M | -3.44M | -3.33M | -3.02M |
Debt Repayment | 373K | 373K | -109K | 844.16K | 1.15M | 1.81M | 2.29M | 1.68M | 2.25M | 2.33M | 2.86M | 3.17M | 3.07M | 2.94M | 2.55M | 3.7M | 5.82M | 5.21M | 4.59M | 3.96M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -482K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | -109K | 373K | -109K | 844.16K | 6.18M | 6.85M | 7.33M | 6.72M | 2.25M | 2.33M | 2.86M | 3.17M | 3.07M | 2.94M | 2.55M | 3.7M | 5.82M | 5.21M | 4.59M | 3.96M |
Net Cash Flow | -614K | -1.3M | -2M | -2.95M | 1.26M | 1.96M | 2.64M | 3.4M | -1K | 1K | -1K | 201K | -27K | 69K | 24K | 68K | 24.7K | -73.3K | -27.3K | -73.33K |
Free Cash Flow | -508K | -1.67M | -1.89M | -3.8M | -4.92M | -4.89M | -4.69M | -3.32M | -2.25M | -2.33M | -2.87M | -3.07M | -3.2M | -3M | -2.52M | -2.67M | -2.36M | -1.82M | -1.28M | -919.89K |
Adj. Free Cash Flow | -521K | -1.66M | -1.91M | -3.8M | -4.92M | -4.92M | -4.69M | -3.32M | -2.25M | -2.33M | -2.87M | -3.07M | -3.2M | -3M | -2.52M | -2.67M | -2.36M | -1.82M | -1.28M | -919.89K |
Maintenance CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1K | -13K | -18K | -294K | -293K | -281K | -276K | n/a | n/a | n/a | n/a | n/a |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | -508K | -1.67M | -1.89M | -3.8M | -4.92M | -4.89M | -4.69M | -3.32M | -2.25M | -2.33M | -2.87M | -3.07M | -3.2M | -3M | -2.52M | -2.67M | -2.36M | -2.24M | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove IBO